- Title
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology
- Creators
- N A Mark Estes, 3rdRichard J KovacsAaron L BaggishRobert J Myerburg
- Publication Details
- Circulation (New York, N.Y.), Vol.132(22), pp.e330-e333
- Publisher
- United States
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Cardiovascular
- Language
- English
- Resource Type
- Journal article
- PMID
- 26621651
- Record Identifier
- 991031577555102976
Journal article
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology
Circulation (New York, N.Y.), Vol.132(22), pp.e330-e333
2015-12-01
PMID: 26621651
Metrics
13 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.141 Hormone Therapy
- 1.141.1092 Testosterone
- Web Of Science research areas
- Cardiac & Cardiovascular Systems
- Peripheral Vascular Disease
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites